Lompat ke isi

Filamen PH

Ensiklopedia Pengetahuan Universitas Islam Sultan Agung
Revisi sejak 29 Agustus 2026 18.10 oleh Maintenance script (bicara | kontrib) (Presentation V4: sitasi, referensi, Math, Wikimedia Commons, dan atribusi)
(beda) ← Revisi sebelumnya | Revisi terkini (beda) | Revisi selanjutnya → (beda)

Filamen PH () adalah tumpukan protein yang ditemukan pertama kali oleh Alois Alzheimer di dalam neuron penderita Alzheimer.[1]

Filamen ini terbentuk dari berbagai isomer[2] protein tau[3] - sebuah protein yang berperan dalam perakitan dan pemeliharaan struktur mikrotubula - mengalami hiperfosforilasi sehingga memecahkan struktur mikrotubula. Radikal protein tau kemudian berhimpun menjadi filamen PH di dalam soma.[4]

Hiperfosforilasi terjadi karena terjadi kerusakan transduksi sinyal seluler yang disebabkan oleh tid ak seimbangnya aktivitas protein dari beberapa enzim fosfatase dan kinase,[5] seperti calmodulin-dependent protein kinase II, glycogen synthase kinase-3beta dan cyclin-dependent protein kinase 5.[6][7] Proses kimiawi ini dapat diredam dengan meningkatkan aktivitas enzim fosfoseril protein fosfatase[8] dan fosfotreonil protein fosfatase.[9]

Referensi

  1. alzi. Apa yang menyebabkan demensia?. Alzheimer Indonesia. 2019-06-15.
  2. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Medical Research Council, Laboratory of Molecular Biology, Cambridge, England; Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA.
  3. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Medical Research Council Laboratory of Molecular Biology, Cambridge, United Kingdom; Goedert M, Wischik CM, Crowther RA, Walker JE, Klug A.
  4. The Role of Tau in Alzheimer's Disease and Related Disorders. Department of Neurobiology and Behavior and Institute for Memory Impairments and Neurological Disorders, University of California; Medeiros R, Baglietto-Vargas D, Laferla FM.
  5. The Role of Tau in Alzheimer's Disease and Related Disorders. Department of Neurobiology and Behavior and Institute for Memory Impairments and Neurological Disorders, University of California; Medeiros R, Baglietto-Vargas D, Laferla FM.
  6. Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention. Department of Neurochemistry New York State Institute for Basic Research in Developmental Disabilities; Iqbal K, Grundke-Iqbal I.
  7. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Pathophysiology Department, Tongji Medical College, Huazhong University of Science & Technology; Wang JZ, Grundke-Iqbal I, Iqbal K.
  8. Inhibition of neurofibrillary degeneration: a promising approach to Alzheimer's disease and other tauopathies. Department of Neurochemistry, New York State Institute for Basic Research in Developmental Disabilities; Iqbal K, Grundke-Iqbal I.
  9. Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach. New York State Institute for Basic Research in Developmental Disabilities; Iqbal K, Alonso AD, Gondal JA, Gong CX, Haque N, Khatoon S, Sengupta A, Wang JZ, Grundke-Iqbal I.

Sumber dan atribusi

Konten artikel ini diadaptasi dari Wikipedia bahasa Indonesia, revisi 26742913 (2025-01-05T05:55:51Z), yang tersedia berdasarkan lisensi Creative Commons Atribusi-BerbagiSerupa (CC BY-SA). Mohon gunakan konten ini secara bijak serta sesuai dengan ketentuan lisensi yang berlaku.